SHERMAN MARK ANDREW

DLB EVP Sherman sold 15,000 shares at $75.02; historically well-timed at 90 days (5 of 5 prior sales fell after)

Mark Andrew Sherman, EVP, General Counsel & Secretary, sold 15,000 shares of Dolby Laboratories at $75.02 on 2025-06-04, reducing his holdings by 19.4% to 62,397 shares. His prior trades at DLB show a consistent timing pattern: all 5 prior sales at this ticker experienced negative 90-day returns, indicating the insider has a track record of selling ahead of subsequent declines. While the current stock price of $74.96 is only 2.1% above the 30-day benchmark and remains 14.2% below the 52-week high of $87.32, the company's fundamentals show modest stress with annual revenue declining 2.0% year-over-year and a relatively elevated P/E of 27.36 against $369.6M in quarterly revenue. The historical pattern at this specific ticker—where all 5 prior sales preceded 90-day declines—combined with the magnitude of this sale, warrants observation of post-trade price action to assess whether the pattern persists.

EVP Sherman sold 40,000 DLB shares for $3.4M at $83.00–$86.00 on 2025-01-30, reducing holdings -39.1%.

Sherman Mark Andrew, EVP, Gen. Counsel & Secretary, executed 2 separate sales totaling 40,000 shares for $3,395,102.50 at blended average price $84.88. His holdings fell from 102,397 shares to 62,397 shares, a -39.1% reduction. This is a material disposition of equity. Sherman's cross-ticker track record shows 3 prior sells with a well-timed rate of 100.00% (all produced negative 90-day returns), and at DLB specifically, 3 of 3 prior sells also generated negative 90-day outcomes, demonstrating consistent timing accuracy on downside moves. The current stock price of $84.14 is -3.6% from the 52-week high and has appreciated +12.9% over 90 days; the sale occurred near the upper end of the 52-week range ($66.75–$87.32). Given Sherman's established pattern of well-timed sales at this ticker and his track record of selling into rallies that subsequently declined, this large block sale warrants investor attention as a potential signal aligned with his demonstrated timing discipline.